Glaucoma: The Silent Thief of Sight
Glaucoma is a group of eye diseases in which elevated intraocular pressure progressively damages the optic nerve, causing irreversible visual field loss. It is the leading cause of irreversible blindness worldwide. This guide covers open-angle and angle-closure glaucoma, how elevated IOP damages the optic nerve, diagnostic tests, eye drop therapy, laser, and surgery.
Published May 18, 2026
Glaucoma: The Silent Thief of Sight
Glaucoma is not a single disease but a group of eye conditions characterised by progressive optic neuropathy — damage to the optic nerve, the cable that carries visual information from the retina to the brain. As retinal ganglion cells (the neurons whose axons form the optic nerve) progressively die, the visual field is eroded from the periphery inwards, ultimately leading to tunnel vision and, untreated, blindness.
Glaucoma is the leading cause of irreversible blindness worldwide, affecting approximately 80 million people. Unlike cataracts, the vision lost to glaucoma cannot be restored. The crucial challenge is that glaucoma is almost entirely asymptomatic until significant, permanent damage has already occurred — earning it the title "the silent thief of sight." Regular screening in at-risk populations is the cornerstone of prevention.
How Glaucoma Damages the Eye
Aqueous Humour and Intraocular Pressure
The eye maintains its shape and pressure through the production and drainage of aqueous humour — a clear fluid produced by the ciliary body, which flows from the posterior chamber, through the pupil, and drains from the anterior chamber via the trabecular meshwork (a spongy tissue at the drainage angle between the iris and cornea) into the Schlemm's canal and episcleral veins.
Intraocular pressure (IOP) is determined by the balance between aqueous production and drainage. The average normal IOP is 15 mmHg (normal range: 10–21 mmHg). Elevated IOP — the most important risk factor for glaucoma — occurs when aqueous drainage is impaired.
How Elevated IOP Damages the Optic Nerve
Elevated IOP compresses the optic nerve head (optic disc) at the point where the nerve fibres exit the eye through the lamina cribrosa — a fenestrated plate of connective tissue that provides structural support for the nerve fibres. Mechanical compression and impaired axoplasmic transport (nutrients flowing along axons) kill retinal ganglion cells. The optic disc develops characteristic changes:
- Increased cup-to-disc ratio (CDR): the cup (central depression) enlarges relative to the disc; CDR >0.6 or asymmetry between eyes is suspicious
- Optic disc pallor: the neuroretinal rim (healthy nerve tissue) becomes pale and thin as fibres die
- Notching: focal loss of the neuroretinal rim, typically at the inferior or superior poles first
- RNFL defects: retinal nerve fibre layer thinning visible on OCT imaging
Important exception: approximately 30–40% of glaucoma patients have optic nerve damage with IOP within the normal range — normal-tension glaucoma (NTG). Vascular factors, reduced optic nerve perfusion, and individual susceptibility of the optic disc play important roles.
Types of Glaucoma
Primary Open-Angle Glaucoma (POAG) — Most Common
The drainage angle between the iris and cornea is anatomically open, but the trabecular meshwork is dysfunctional — drainage resistance is increased, IOP rises slowly over years. POAG is the most common form in White and Black populations worldwide.
Characteristics:
- Slow, painless onset — no symptoms until advanced
- Bilateral, though often asymmetric
- Progressive peripheral visual field loss (scotomas), typically starting as small areas of reduced sensitivity that coalesce into arcuate defects, then nasal steps, ultimately sparing only central vision
- IOP typically elevated but can be normal (NTG)
Risk factors for POAG: age (risk doubles each decade after 40); elevated IOP; thin central cornea (thinner cornea means true IOP may be underestimated); myopia (particularly high myopia); Black African or Caribbean ethnicity (3–4× increased risk, earlier onset, more aggressive); positive family history (4× risk if first-degree relative affected); optic disc findings (large disc, large cup).
Primary Angle-Closure Glaucoma (PACG)
The anatomical drainage angle between the iris and cornea is narrow or closed, physically obstructing aqueous outflow. More common in East Asian populations (Chinese, Vietnamese, Thai), hyperopic (far-sighted) patients, and women.
Chronic angle closure: Insidious, similar to POAG but with a narrow drainage angle; often discovered incidentally.
Acute angle-closure crisis (glaucoma attack): Rapid, complete closure of the drainage angle causes sudden severe IOP elevation (50–80 mmHg), producing:
- Sudden, severe eye pain — may radiate to the forehead or cause headache and nausea/vomiting (mimicking migraine or acute abdomen)
- Sudden visual blurring and halos around lights
- Red eye (conjunctival injection)
- Fixed, semi-dilated, unreactive pupil
- Rock-hard eye on palpation
- Medical emergency: vision can be permanently lost within hours; immediate treatment required
Secondary Glaucomas
- Pseudoexfoliation glaucoma: fibrillar material deposits on the lens and clogs the trabecular meshwork; associated with high IOP and rapid progression; more common in Scandinavian and Middle Eastern populations
- Pigmentary glaucoma: pigment granules shed from the iris clog the meshwork; young myopic men; IOP spikes with exercise
- Neovascular glaucoma: new blood vessel proliferation (from diabetic retinopathy or CRVO) closes the drainage angle; very high IOP; poor prognosis
- Steroid-induced glaucoma: topical, systemic, or intravitreal corticosteroids can raise IOP in genetically susceptible individuals ("steroid responders")
- Traumatic glaucoma: blunt trauma damages the trabecular meshwork (angle recession glaucoma)
Diagnosis
Early diagnosis requires active case-finding — most patients are asymptomatic.
Intraocular Pressure Measurement (Tonometry)
Goldmann applanation tonometry — the gold standard; measures the force required to flatten a standard area of the cornea. IOP varies throughout the day (diurnal variation); single readings can miss elevated IOP.
Pachymetry — central corneal thickness measurement; thin corneas underestimate true IOP; thick corneas overestimate IOP.
Optic Disc Examination
Slit-lamp biomicroscopy with a fundus lens examines the optic disc for cup-to-disc ratio, neuroretinal rim appearance, disc haemorrhages (a sign of active damage), and peripapillary atrophy.
Optical coherence tomography (OCT) — the most sensitive structural test. OCT quantifies:
- Retinal nerve fibre layer (RNFL) thickness — compared to normative databases
- Ganglion cell complex (GCC) analysis — detects macular ganglion cell loss
- Optic disc parameters (CDR, rim area)
OCT can detect structural damage before visual field defects appear (pre-perimetric glaucoma).
Visual Field Testing (Perimetry)
Standard automated perimetry (Humphrey visual field analyser) maps the patient's visual field by presenting light stimuli at standardised locations. Glaucomatous defects follow the arcuate pattern of retinal nerve fibre bundles. Regular visual field testing every 6–12 months is essential to monitor progression.
Gonioscopy
A special mirrored contact lens allows direct visualisation of the drainage angle — essential to classify glaucoma as open-angle or closed-angle and guide treatment decisions.
Treatment
Eye Drop Therapy (First-Line)
IOP reduction — the only proven strategy to prevent glaucomatous progression — is the cornerstone of all glaucoma treatment. Every 1 mmHg reduction in IOP reduces the risk of glaucoma progression by approximately 10%.
| Drug Class | Example | IOP Reduction | Mechanism |
|---|---|---|---|
| Prostaglandin analogues | Latanoprost, bimatoprost, travoprost | 25–33% | Increases uveoscleral outflow; once daily |
| Beta-blockers | Timolol, betaxolol | 20–25% | Reduces aqueous production; avoid in asthma |
| Alpha-2 agonists | Brimonidine | 20–25% | Reduces aqueous production; increases outflow |
| Carbonic anhydrase inhibitors | Dorzolamide, brinzolamide | 15–20% | Reduces aqueous production |
| Rho-kinase inhibitors | Netarsudil | 20–25% | Increases trabecular outflow; newer class |
| Combination drops | Xalacom, DuoTrav | 30–35% | Two agents in one bottle; improves adherence |
Prostaglandin analogues are first-line in most patients — once-daily dosing and greatest IOP-lowering effect. Adherence is the primary challenge in chronic glaucoma management.
Laser Treatment
Laser trabeculoplasty (SLT — Selective Laser Trabeculoplasty): Low-energy laser applied to the trabecular meshwork opens channels and improves drainage. Now accepted as a first-line treatment alternative to eye drops in POAG. Reduces IOP by 20–30%; effects last 3–5 years and can be repeated. No surgical risks.
Peripheral laser iridotomy (LPI): Creates a small hole in the iris with laser to bypass pupillary block — definitive treatment for acute angle-closure crisis and prevention of attacks in narrow-angle patients.
Surgery
When eye drops and laser fail to achieve target IOP or disease progresses despite treatment:
Trabeculectomy — the classic glaucoma filtration surgery. A scleral flap is created, a small section of the trabecular meshwork is removed, and aqueous drains from the anterior chamber into a subconjunctival bleb (a fluid-filled blister under the conjunctiva), from where it is absorbed. Highly effective — can reduce IOP to 8–12 mmHg. Complications: bleb infection (blebitis, endophthalmitis), hypotony, cataract acceleration.
Glaucoma drainage devices (tube shunts): A tube is placed in the anterior chamber connecting to a plate sutured to the sclera. Used when trabeculectomy is likely to fail (previous surgery, severe conjunctival scarring, neovascular glaucoma). Examples: Baerveldt, Ahmed, Molteno implants.
Minimally invasive glaucoma surgery (MIGS): A newer class of procedures that offer a safer profile with a modest IOP-lowering effect; performed in conjunction with cataract surgery. Examples: iStent Inject, Hydrus Microstent (trabecular bypass), XEN gel stent (subconjunctival drainage).
Acute angle-closure crisis management: IV acetazolamide, IV mannitol, topical beta-blocker and alpha-agonist to rapidly lower IOP; followed by laser iridotomy once the acute episode is controlled.
Glaucoma Care in China
China's glaucoma and ophthalmology centres offer:
- Comprehensive glaucoma workup: Goldmann tonometry, OCT RNFL and GCC analysis, Humphrey visual field, pachymetry, and gonioscopy
- 24-hour IOP monitoring: phased tonometry to detect diurnal IOP fluctuations and peak pressures missed by single readings
- SLT laser trabeculoplasty: selective laser trabeculoplasty available
- High-volume trabeculectomy and tube surgery: experienced glaucoma surgeons with annual volumes comparable to major UK centres; mitomycin-C augmented surgery for high-risk cases
- Full MIGS programme: iStent, Hydrus, and XEN procedures combined with cataract surgery
- Acute angle-closure: 24/7 emergency ophthalmology for acute angle-closure crisis management
- Cost: care in China is generally less expensive than UK private treatment, but the hospital prices each case individually — ask us for the written quote before you commit.
- Full English care navigation from first appointment through surgery and ongoing monitoring
Contact a ChinaMedicalTour care navigator to arrange a glaucoma assessment, IOP monitoring, or surgical consultation.
Medical content based on MSD Manuals and international glaucoma guidelines. Evidence reviewed 2025.
Frequently Asked Questions
Can international patients schedule comprehensive eye examinations and specialist consultations in China?
Yes. Comprehensive ophthalmic evaluations including optical coherence tomography (OCT), visual field testing, corneal topography, and fundus photography are coordinated at specialized eye hospitals.
What specialized ophthalmic treatments and laser therapies are evaluated in China?
Tertiary ophthalmology centers offer micro-incision cataract surgery, anti-VEGF intravitreal injections, retinal photocoagulation, and minimally invasive glaucoma procedures tailored to individual eye pathology.
How is post-treatment follow-up handled for traveling eye patients?
Follow-up visual checks, eye drop regimens, and detailed bilingual ophthalmic clinical notes are provided upon discharge to ensure seamless continuation with domestic eye care providers.
© 2026 北京问道行文旅科技有限公司 / China Medical Tour. All rights reserved.
Need a custom recommendation?
Share your goals and we will craft a personalized medical travel plan.